TAKEDA PHARMACEUTICAL CO LTD
CIK: 0001395064SEC EDGAR →
Portfolio Value
$16.4B
Holdings
8
As of
Q3 2025
New Positions
0
Closed Positions
2
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Ovid Therapeutics, Inc. | 7,531,996 | $9.8B | 59.82% |
| 2 | Equillium, Inc. | 1,824,977 | $2.6B | 15.94% |
| 3 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 1,475,121 | $1.2B | 7.59% |
| 4 | Shattuck Labs, Inc. | 515,619 | $1.2B | 7.53% |
| 5 | Lyell Immunopharma, Inc. | 54,887 | $891.4M | 5.45% |
| 6 | American Well Corporation | 77,733 | $478.1M | 2.92% |
| 7 | Rani Therapeutics Holdings, Inc. | 203,190 | $101.6M | 0.62% |
| 8 | Standard Biotools, Inc. | 16,515 | $21.5M | 0.13% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 7 | $16.3B | 99.9% |
| Unknown | 1 | $21.5M | 0.1% |